Prof.
Stanley Zaslau
West
Virginia University, USA
Email:
szaslau@hsc.wvu.edu
Qualifications
1994
Ph.D., Hahnemann University School of Medicine, USA
1990
M.Sc., College of Osteopathic Medicine, USA
1988
B.Sc., Boston University College of Liberal Arts, USA
Publications (Selected)
-
Marchetti, K. A., Ferreri, C. A., Bethel, E. C., Lesser-Lee, B., Daignault-Newton, S., Merrill, S., ... & Kraft, K. H. (2024). Gender-based Disparity Exists in the Surgical Experience of Female and Male Urology Residents. Urology, 185, 17-23.
-
Goudelocke, C., Sobol, J., Poulos, D., Enemchukwu, E., Zaslau, S., & Dhir, R. (2024). A multicenter study evaluating the FREquency of use and efficacy of a novel closed-loop wearable tibial neuromodulation system for overactive bladder and urgency urinary incontinence (FREEOAB). Urology, 183, 63-69.
-
Margolin, E. J., Schoenfeld, D., Miles, C. H., Merrill, S. B., Raman, J. D., Thompson, R. H., ... & Badalato, G. M. (2023). Longitudinal changes in the operative experience for junior urology residents. Urology, 179, 32-38.
-
Trump, T., Mitchell, K., Werner, Z., Duenas-Garcia, O., Shapiro, R., & Zaslau, S. (2023). Assessing the effectiveness of antimicrobial pouch use for infection prevention in sacral neuromodulation. International Urogynecology Journal, 34(10), 2513-2517.
-
Goudelocke, C., Xavier, K., Pecha, B., Burgess, K., Perrouin‐Verbe, M. A., Krlin, R., ... & Nitti, V. (2023). Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6‐month results from the global postmarket ELITE study. Neurourology and Urodynamics, 42(4), 761-769.
-
Perrouin-Verbe, M. A., Goudelocke, C., Xavier, K., Pecha, B., Burgess, K., Krlin, R., ... & Nitti, V. (2023). Device programming of the rechargeable InterStim Micro sacral neuromodulation device through 12 months in a global post-market study.
-
Luketich, S. K., Zekan, D. S., Prisneac, I., Howell, D. M., El Naili, R., & Zaslau, S. (2023). EBV-positive diffuse large B-cell lymphoma presenting as symptomatic masses in the bladder trigone and unilateral kidney. Urology Case Reports, 47, 102355.
-
Peyronnet, B., Elterman, D., Goudelocke, C., Xavier, K., Pecha, B., Burgess, K., ... & Perrouin-Verbe, M. (2022). Évaluation des performances cliniques et de la sécurité de l’InterStim™ micro-rechargeable chez les sujets atteints d’hyperactivité vésicale: résultats à 6 mois de l’étude Elite. Progrès en Urologie-FMC, 32(3), S49.
-
Werner, Z., Trump, T., Zaslau, S., & Shapiro, R. (2023). Assessing comprehension of online information in the United States for third-line treatment of overactive bladder. International Urogynecology Journal, 34(3), 701-705.
-
Xavier, K., Goudelocke, C., Pecha, B., Burgess, K., Perrouin-Verbe, M. A., Krlin, R., ... & Nitti, V. (2022). MP18-10 EVALUATION OF CLINICAL PERFORMANCE AND SAFETY FOR THE RECHARGEABLE INTERSTIMTM MICRO IN OVERACTIVE BLADDER SUBJECTS: 3-MONTH RESULTS FROM THE GLOBAL POST-MARKET ELITE STUDY. Journal of Urology, 207(Supplement 5), e299.
Profile Details
https://directory.hsc.wvu.edu/Profile/32689
https://www.linkedin.com/in/stanley-zaslau-md-mba-facs-3a860333/
https://www.researchgate.net/scientific-contributions/Stanley-Zaslau-39376296